![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Mueck Wolfgang
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.47, Iss.3, 2008-01, pp. : 203-216
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rivaroxaban, the first oral, direct factor Xa inhibitor
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)